European Board in Neuroendocrine Neoplasia Medicine

Welcome to the website of the European Board of Neuroendocrine Neoplasia Medicine. We are delighted to have gained your interest and to share with you our vision and goals for the development of patient care and postgraduate medical education in Neuroendocrine Neoplasia Medicine.

By successfully completing this programme, candidates will receive a official certification and an EU-wide recognised accreditation in neuroendocrine neoplasia medicine by the governing body UEMS. This programme is comparable to other European Board offers organised by the UEMS in association with other medical societies.

Vision, purpose, key objectives


To serve patients, physicians and scientists throughout Europe and beyond by providing postgraduate medical education and training of the highest quality in the specialty of Neuroendocrine Neoplasia (NEN) Medicine.


To stimulate and enhance highest quality patient care by promoting and harmonising professional standards for medical practice, training and continuous postgraduate medical education, and thus clinical excellence.

Key objectives

  • To define, secure and assess the standards of training in NEN Medicine throughout Europe and beyond
  • To provide continuous medical education (CME) and continuous professional development (CPD) in Europe and beyond in conjunction with ENETS.
  • To promote exchange of trainee NEN specialists internationally
  • To motivate medical doctors to engage in the specialist field of NEN
  • To establish a specialty for NEN representing the interdisciplinary group of experts in this field.

History of EBNEN

To learn more about the history of the European Board in Neuroendocrine Neoplasia Medicine, please click on the button below.

European Board of NEN Medicine

The European Board of NEN Medicine (EBNEN) has been established by the UEMS and ENETS to guarantee the highest standards of training and care in the field of neuroendocrine neoplasiamedicine in the countries of the European Union and associated partner countries.  

The European Board in Neuroendocrine Neoplasia Medicine, has been created to ensure that the training in neuroendocrine neoplasia medicine as well as scientific progress and interaction are raised to the highest possible level. The cooperation between UEMS and ENETS has been sealed with the Memorandum of Understanding (MoU).

The routine business of the European Board in Neuroendocrine Neoplasia Medicine carried out by an Executive Committee, composed of the two Executice Committee Chairs, the Secretary, the Treasurer, both, the Chairs of the European Board in Neuroendocrine Neoplasia Medicine Training and Examination Committees,  as well as the Chair, Vice-Chair, Chair Elect of ENETS, and the Chair of the Advisory Board of the ENETS.

The Executive Board and delegates meet twice a year – in parallel to the ENETS Ad Board meetings.

Memorandum of Understanding

Click below to read the Memorandum of Understanding (MoU) between ENETS and the UEMS.

Executive Board


Andrea Frilling, United Kingdom
Executive Committee Chair MJC EBNEN (rotating)

Ok Pascher 300dpi

Andreas Pascher, Germany
Executive Committee Chair MJC EBNEN (rotating)


Anna Koumarianou, Greece
EBNEN Secretary


Ulrich-Frank Pape, Germany
EBNEN Working Group Member


Nicola Fazio, Italy
Chair EBNEN Training Committee

K-ok-Bartsch 200x200

Detlef Bartsch, Germany
ENETS Treasurer


Eva Tiensuu Janson, Sweden
ENETS Vice-Chair


Delegates from core disciplines:

  • Surgery - Elisabeth NIEVEEN VAN DIJKUM, the Netherlands   
  • Oncology - Marc PEETERS, Belgium
  • Endocrinology - Simona GLASBERG, Israel
  • Radiology - Anders SUNDIN, Sweden
  • Pathology - Aurel PERREN, Switzerland
  • Nuclear medicine - Jaroslaw CWIKLA, Poland
  • Gastroenterology - Anja RINKE, Germany
  • INCA Representative - Mark McDONNELL, Ireland

Delegates of Trainees - to be selected every 2 years